The AST:ALT ratio compares two liver enzymes, computed automatically from your liver panel.
A ratio above 1 points away from simple fatty liver toward other causes of enzyme rise such as alcohol, muscle injury or advanced liver change; below 1 is the usual pattern when ALT drives a rise.
Optimal AST:ALT Ratio: 0-1 ratio.
Typically re-tested every 12 weeks.
A result below 1 means ALT is the higher of the two enzymes. A result above 1 means AST is. Both patterns turn up in people whose liver tests are otherwise unremarkable, so the number earns its meaning from the rest of the panel and from what has been happening in the days before the draw.
The AST:ALT ratio is aspartate aminotransferase divided by alanine aminotransferase from the same blood sample, a single unitless number that describes which of the two enzymes is dominant.
Both enzymes are aminotransferases, meaning they move amino groups between molecules as part of normal amino acid handling. They work inside cells rather than in the bloodstream, so the amount circulating in blood is mostly a measure of leakage. When cell membranes are stressed or cells break down, the enzymes spill out and the serum level rises.
The reason the two are compared is that they are not stored in the same places. ALT sits in high concentration in the cytosol of liver cells and in relatively little else, which makes it the more liver-specific of the pair. AST is abundant in the liver too, but also in heart muscle, skeletal muscle, kidney, brain and red blood cells, and it exists in two forms, one in the cytosol and one inside mitochondria. Injury that reaches the mitochondria tends to release more of the mitochondrial form. AST is also cleared from the circulation more quickly than ALT, so the two enzymes fall at different speeds once an insult has passed.
Put those differences together and the ratio becomes a crude direction-finder. The comparison is often called the De Ritis ratio, after the clinician who described it in the 1950s, and reviews of its use note that it has survived decades of practice because it adds context to enzyme values that are otherwise hard to interpret in isolation 1.
It matters because the direction of the enzyme pattern carries information that neither enzyme gives alone, and because the AST to ALT relationship feeds into several widely used non-invasive liver scores.
The liver is a quiet organ. Fat accumulation, inflammation and early scarring often progress for years with no symptoms and with routine enzymes that look unremarkable or only mildly raised. Blood markers are one of the few low-burden ways to notice drift early. In research comparing non-invasive methods against transient elastography in people with non-alcoholic fatty liver disease, the AST/ALT ratio was assessed alongside FIB-4 and APRI, two scores that also build on AST, as a way of estimating hepatic fibrosis without a biopsy 2. None of these scores replaces imaging or specialist assessment, but they help a clinician decide who needs a closer look.
Interest in the ratio has also widened beyond the liver. A broad review of its use across clinical medicine describes associations reported in cardiovascular, oncological and metabolic settings, where a higher ratio has been linked with poorer outcomes in several populations 3. Those associations are observational and the ratio is not a standalone risk score, so it is best understood as a signal that prompts further questions rather than an answer in itself.
For someone tracking long-term health, the useful habit is trend-watching. A ratio that is stable across years, with both enzymes inside range, is reassuring context. A ratio that climbs while enzymes also climb is the pattern worth raising with a clinician.
Most laboratories regard an AST:ALT ratio up to around 2 as within the reported reference interval, while FitScript's optimal range is tighter.
| Measure | Typical lab reference range | FitScript optimal range |
|---|---|---|
| AST:ALT ratio | 0 to 2 (unitless) | 0 to 1 (unitless) |
Reference ranges vary by laboratory, assay, age and sex, so always read your result against the range printed on your own report. FitScript's optimal range is an optimization target, not a diagnostic cut-off, and a value outside it is not a finding on its own.
Two cautions matter more than the numbers. First, the ratio is close to meaningless when both enzymes sit comfortably inside their own reference intervals, because small random variation in two small numbers can swing a quotient a long way. Second, the ratio never replaces the absolute values. A ratio of 1.0 built from two normal enzymes and a ratio of 1.0 built from two markedly raised enzymes describe completely different situations. Published guidance on assessing adults with persistently raised transaminases and no symptoms sets out a stepwise approach that starts with repeating the test and reviewing history, alcohol intake, medication and metabolic risk, rather than acting on a single reading 4.
If you want the arithmetic done for you from your own two values, the AST to ALT ratio calculator handles it.
Related: Can Hypothyroidism Cause Elevated ALT and AST?
A high result means AST is the dominant enzyme, and its interpretation depends almost entirely on whether the enzymes themselves are raised and where the AST might be coming from.
What people notice. The ratio produces no symptoms of its own. People whose results sit here sometimes report nothing at all. Others describe fatigue, a dull fullness under the right ribs, reduced appetite, nausea, or unusually heavy muscle soreness and dark urine after hard training when skeletal muscle is contributing. Yellowing of the eyes or skin, swelling or easy bruising are features of advanced liver disease and are reasons to contact a clinician promptly rather than wait for the next scheduled draw.
Common causes. Classically, a ratio above 2 with only modest absolute enzyme elevations has been associated with alcohol-related liver injury, a pattern described in older and more recent diagnostic work on the De Ritis ratio 5, often alongside a raised gamma-glutamyl transferase 6. Non-liver sources matter too, including recent strenuous exercise, muscle injury, haemolysis of the blood sample, and cardiac or muscle conditions. Case series have also reported markedly elevated ratios as a clue to hepatic neoplasia, which is one reason a striking and unexplained result is followed up rather than repeated indefinitely 7.
Why it is followed. A persistently high ratio accompanied by persistently raised enzymes is associated with more established liver injury, and the long-term concern is scarring that progresses silently. A single suboptimal value is a prompt for context, history and repeat testing with a clinician, not a conclusion.
A low result means ALT is the dominant enzyme, which is the usual arrangement in healthy adults and the most common pattern in early metabolic liver changes.
What people notice. Usually nothing. A ratio below 1 with normal enzymes is unremarkable and needs no action. Where ALT is raised and driving the ratio down, people sometimes report tiredness, expanding waist measurement, or vague upper abdominal discomfort, but many describe no symptoms whatsoever and the finding arrives through routine bloodwork.
Common causes. When ALT is elevated and AST is not, the pattern is frequently seen in fat accumulation in the liver linked to insulin resistance and excess body fat. It also appears in acute viral hepatitis and in some medication-related or supplement-related liver injury, where ALT typically rises steeply.
Why it still gets attention. A low ratio is not a clean bill of health. It does not exclude fibrosis, and a raised ALT with a low ratio still deserves the same structured assessment recommended for any persistent transaminase elevation without symptoms 4. Liver fat is associated with insulin resistance and broader cardiometabolic risk, so the useful next step is usually a conversation about metabolic markers rather than about the liver alone.
Plenty, which is why one reading rarely settles anything. The ratio moves whenever either enzyme moves, and several of the influences have nothing to do with liver disease.
FitScript does not currently include the AST:ALT ratio in a lab panel, so this page is here to explain the marker rather than to sell a test for it.
If you already have AST and ALT results from any laboratory, you can upload your labs and have Atlas, the AI health advisor, read them alongside the rest of your bloodwork. That matters because the ratio is one of the clearest examples of a number that means little by itself and a great deal in company. Atlas looks at the absolute enzyme values, the direction of travel across previous draws, and the related liver and metabolic markers, then writes that interpretation into your FitScript so the context travels with the number. Membership includes 150+ biomarkers tested per year, which is what makes trend reading possible rather than guesswork from a single snapshot.
Interpretation is not prescribing. Where a result raises a question that might call for medication or any other prescription therapy, a licensed provider evaluates whether it is appropriate after reviewing you as a person, not as a value on a chart. This article is educational and is not medical advice, and you should discuss your own results or treatment options with a clinician or licensed provider.
The ratio is only as useful as the panel around it. These are the companions that give it meaning.
A platelet count, fasting glucose, insulin and a lipid panel are also commonly read with these, because metabolic drivers sit behind a large share of abnormal liver enzymes.
The AST:ALT ratio is a comparison, not a verdict. Below 1 is the ordinary arrangement and the typical early metabolic pattern. Above 1, and particularly well above it, shifts attention toward alcohol-related injury, more established scarring or a non-liver source of AST, and a markedly high unexplained value is worth discussing with a clinician promptly. The number only becomes informative once you know what the two enzymes are doing in absolute terms, what the rest of the panel shows, and what the previous results looked like.
For more background on the two enzymes behind the number, read what is sgot ast blood test and when to worry about alt levels.
Most laboratories report values up to around 2 as within the standard reference interval, and FitScript's optimal range is 0 to 1. Those are population ranges and optimization targets, not diagnostic cut-offs. A ratio is only informative once you also know whether AST and ALT themselves sit inside their own reference ranges, since a quotient built from two normal enzymes tells you very little.
No. A ratio above 1 simply means AST is the higher of the two enzymes, and that happens in plenty of people with unremarkable liver tests. Recent hard training, a haemolysed sample, more muscle mass or ordinary day-to-day variation can all produce it. The result that attracts attention is a high ratio alongside enzymes that are themselves raised and staying raised.
Older and more recent diagnostic work on the De Ritis ratio has associated a value above 2, usually with only modest absolute enzyme elevations and often with a raised GGT, with alcohol-related liver injury. It is an association rather than a test for drinking, and reviews of alcohol markers note that no single blood value is definitive. A clinician reads it with history and other markers.
Yes. Skeletal muscle contains a good deal of AST, so heavy resistance work, long endurance sessions or unfamiliar training can raise AST more than ALT and push the ratio up for several days. Published guidance on assessing raised transaminases includes repeating the test after a stretch without strenuous exertion before drawing any conclusions.
ALT being the dominant enzyme, which is the ordinary arrangement in most adults. Where ALT is also elevated, that pattern is commonly seen in fat accumulation in the liver associated with insulin resistance, and in acute viral or medication-related liver injury. A low ratio does not rule out fibrosis, so a persistently raised ALT still deserves assessment with a clinician.
Not on its own. The AST to ALT relationship feeds into non-invasive fibrosis scores such as FIB-4 and APRI. They help identify who needs closer assessment. Imaging, elastography and specialist review remain the tools that characterise scarring.
Start with the two enzymes themselves, AST and ALT, then add GGT for biliary and alcohol-related patterns, albumin for synthetic function, total bilirubin for clearance, and globulin for the protein picture. Platelet count, fasting glucose, insulin and a lipid panel are also commonly read alongside, because metabolic drivers sit behind many abnormal liver enzymes.
FitScript does not currently include this ratio in a lab panel. If you already have AST and ALT results from any laboratory, you can upload your labs and Atlas will read them alongside your other markers and previous draws, then write that context into your FitScript. Any question about prescription treatment is evaluated by a licensed provider.
That depends on the absolute enzyme values, your history and what a clinician is watching for, so the interval is a clinical decision rather than a fixed rule. What helps in every case is consistency, using the same laboratory where possible and avoiding strenuous exercise and alcohol before the draw so that consecutive results are comparable.